CYP2D6*10 polymorphisms and lung cancer susceptibility

Acta Academiae Medicinae Sinicae

Volumn 30, Issue 5, 2008, Pages 564-568

  Yan, Zhen ^a   Wu, Yi Ming ^a   Wu, Yong Jun ^a  

^a ZHENGZHOU UNIVERSITY   (China)

Author keywords

CYP2D6; Lung cancer susceptibility; Single nucleotide polymorphism

Indexed keywords

CYTIDINE; CYTOCHROME P450 2D6; GUANOSINE; THYMIDINE;

ADULT; ARTICLE; CANCER PATIENT; CANCER RISK; CANCER SUSCEPTIBILITY; CASE CONTROL STUDY; CONTROLLED STUDY; FEMALE; GENETIC CORRELATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; HIGH RISK POPULATION; HUMAN; LUNG CANCER; LUNG CARCINOGENESIS; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PROTECTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING; AGED; ASIAN; CHINA; GENETIC PREDISPOSITION; GENETICS; LUNG TUMOR; MIDDLE AGED; RISK FACTOR;

AGED; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; CHINA; CYTOCHROME P-450 CYP2D6; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; SMOKING;

EID: 56349166278     PISSN: 1000503X     EISSN: None     Source Type: Journal    
DOI: 10.3881/j.issn.1000-503X.2008.05.012     Document Type: Article

References (12)

1. Roberts RL, Kennedy MA. Rapid detection of common cytochrome P450 2D6 alleles in Caucasians [J]. Clin Chim Acta, 2006, 366(1-2):348-351.
2. Bradford LD. CYP2D6 allele frequency in European Caucasians, Asians, Africans and their descendants [J]. Pharmacogenomics, 2002, 3(2):229-243.
3. Zackrisson AL, Lindblom B. Identification of CYP2D6 alleles by single nucleotide polymorphism analysis using pyrosequencing [J]. Eur J Clin Pharmacol, 2003, 59(7): 521-526.
4. Gronau S, Koenig Greger D, Jerg M, et al. 11 Beta-hydroxysteroid dehydrogenase 1 expression in squamous cell carcinomas of the head and neck [J]. Clin Otolaryngol, 2002, 27(6):453-457.
5. Agundez JA, Gallardo L, Ledesma MC, et al. Functionally active duplications of the CYP2D6 gene are more prevalent among larynx and lung cancer patients [J]. Oncology, 2001, 61(1):59-63.
6. Zienolddiny S, Campa D, Lind H, et al. A comprehensive analysis of phase I and phase II metabolism gene polymorphisms and risk of non-small cell lung cancer in smokers [J]. Carcinogenesis, 2008, 29(6):1164-1169.
7. Agundez JA, Gallardo L, Ledesma MC, et al. Functionally active duplications of the CYP2D6 gene are more prevalent among larynx and lung cancer patients [J]. Oncology, 2001, 61(1):59-63.
8. Saarikoski ST, Sata F, Husgafvel-Pursiainen K, et al. CYP2D6 ultrarapid metabolizer genotype as a potential modifier of smoking behaviour [J]. Pharmacogenetics, 2000,10 (1):5-10.
9. Gao Y, Zhang Q. Polymorphisms of the GSTM1 and CYP2D6 genes associated with susceptibility to lung cancer in Chinese [J]. Mutat Res, 1999, 444(2):441-449.
10. Chinese source.
11. Chinese source.
12. Chinese source.